Understanding how combinations of immune boosters work together
Molecular Mechanisms of Adjuvant Triplet Combinations
This study is looking at how different immune system boosters can work together to make vaccines more effective, helping researchers find better ways to protect people from illnesses.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11032048 on NIH RePORTER |
What this research studies
This research investigates how different combinations of immune system boosters, known as adjuvants, can enhance the body's response to vaccines. By studying the interactions between these adjuvants and immune cells, particularly CD4+ and CD8+ T cells, the researchers aim to uncover the molecular mechanisms that lead to stronger and more effective immune responses. The approach involves comparing the effects of various combinations of adjuvants in laboratory settings, which may eventually inform the design of more effective vaccines for humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from improved vaccine responses, particularly those with weakened immune systems or those who are unresponsive to current vaccines.
Not a fit: Patients who are not seeking vaccination or those with conditions that contraindicate vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide better protection against infectious diseases.
How similar studies have performed: Previous research has shown promise in using combinations of immune boosters to enhance vaccine efficacy, suggesting that this approach may lead to significant advancements.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Chevrier, Nicolas — University of Chicago
- Study coordinator: Chevrier, Nicolas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.